- Home
- FLS vs ROIV Comparison
FLS vs ROIV Comparison
Compare FLS & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLS
- ROIV
- Stock Information
- Founded
- FLS 1790
- ROIV 2014
- Country
- FLS United States
- ROIV United Kingdom
- Employees
- FLS N/A
- ROIV N/A
- Industry
- FLS Fluid Controls
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- FLS Industrials
- ROIV Health Care
- Exchange
- FLS Nasdaq
- ROIV Nasdaq
- Market Cap
- FLS 8.3B
- ROIV 8.4B
- IPO Year
- FLS N/A
- ROIV N/A
- Fundamental
- Price
- FLS $51.62
- ROIV $10.79
- Analyst Decision
- FLS Strong Buy
- ROIV Buy
- Analyst Count
- FLS 9
- ROIV 4
- Target Price
- FLS $64.11
- ROIV $17.50
- AVG Volume (30 Days)
- FLS 1.7M
- ROIV 5.9M
- Earning Date
- FLS 04-29-2025
- ROIV 05-29-2025
- Dividend Yield
- FLS 1.63%
- ROIV N/A
- EPS Growth
- FLS 20.22
- ROIV N/A
- EPS
- FLS 2.14
- ROIV N/A
- Revenue
- FLS $4,614,870,000.00
- ROIV $122,585,000.00
- Revenue This Year
- FLS $7.11
- ROIV N/A
- Revenue Next Year
- FLS $3.67
- ROIV N/A
- P/E Ratio
- FLS $24.10
- ROIV N/A
- Revenue Growth
- FLS 4.23
- ROIV 140.04
- 52 Week Low
- FLS $37.34
- ROIV $8.73
- 52 Week High
- FLS $65.08
- ROIV $13.06
- Technical
- Relative Strength Index (RSI)
- FLS 65.96
- ROIV 50.06
- Support Level
- FLS $46.34
- ROIV $10.58
- Resistance Level
- FLS $52.50
- ROIV $11.77
- Average True Range (ATR)
- FLS 1.20
- ROIV 0.34
- MACD
- FLS 0.82
- ROIV -0.07
- Stochastic Oscillator
- FLS 90.25
- ROIV 17.65
About FLS Flowserve Corporation
Flowserve Corp is a manufacturer and aftermarket service provider of comprehensive flow control systems. It develops precision-engineered flow control equipment to monitor movement and protect customers' materials and processes. It offers an extensive range of pumps, valves, seals, and services for several industries, including oil and gas, chemical, power generation, and water management. In addition, Flowserve has a network of Quick Response Centers to provide aftermarket equipment services. The aftermarket services help customers with installation, diagnostics, repair, and retrofitting. Sales are roughly split across many regions, with North America and Europe contributing the majority of total revenue.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.